Skip to main content
OpenTrials
Completed

NCT Number: NCT04668638

Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome

The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHR d'Orléans

Orléans, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Positive hyperventilation syndrome diagnosis
  • Having a social security insurance
  • Being at least 18 years old
  • Having given their written consent

Exclusion criteria

  • Being put under guardianship or curatorship
  • Having seen a physiotherapist for a respiratory rehabilitation in the last three months
  • Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, …)
  • Not being able to receive the respiratory rehabilitation from our care providers
  • Already having received a rehabilitation for hyperventilation syndrome
  • Not speaking French or not being unable to complete the questionnaires

Treatment and study plan

respiratory rehabilitation

Other

Respiratory rehabilitation includes education, hypoventilation exercises, diaphragmatic breathing exercises, relaxation, retraining, others.

Primary outcomes

  1. Incidence of respiratory rehabilitation on Quality of life

    Time frame: Day 0

    Quality of life will be evaluated with the SF-36 score

  2. Incidence of respiratory rehabilitation on Quality of life

    Time frame: Month 2

    Quality of life will be evaluated with the SF-36 score

  3. Incidence of respiratory rehabilitation on Quality of life

    Time frame: Month 4

    Quality of life will be evaluated with the SF-36 score

Secondary outcomes

  1. Change in symptomatology

    Time frame: Day 0

    Change in symptomatology will be evaluated on the Nijmegen questionnaire

  2. Change in symptomatology

    Time frame: Month 2

    Change in symptomatology will be evaluated on the Nijmegen questionnaire

  3. Change in symptomatology

    Time frame: Month 4

    Change in symptomatology will be evaluated on the Nijmegen questionnaire

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional d'Orléans

Other

Registry information

Official study title

Impact of Respiratory Rehabilitation on Quality of Life, Measures by the SF-36 Score, in Patients With Hyperventilation Syndrome: Crossover, Prospective and Randomized Study

Acronym: RESPIR-HVS

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Dec 16, 2020
Registry last updated
Jul 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.